DAVID BALTIMORE
CIK 1185858 · last filed 2025-06-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$11.47M
Companies
3
Total Filings
51
Lifetime Open-Market Net
-$4.04M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 3 of 6
51 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-06-02 | AMGN | Sell (S) | −3,700 | -$569.5K | EDGAR |
| 2017-06-02 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-05-03 | AMGN | Grant (A) | +1,230 | $0 | EDGAR |
| 2017-01-06 | — | Grant (A) | — | $0 | |
| 2016-06-03 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-05-05 | AMGN | Grant (A) | +1,279 | $0 | EDGAR |
| 2016-05-03 | AMGN | Sell (S) | −3,312 | -$520.7K | EDGAR |
| 2016-03-31 | AMGN | Mixed | +3,312 | -$139 | EDGAR |
| 2016-01-06 | — | Grant (A) | — | $0 | |
| 2015-06-26 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.